The MHRA's three‐pronged strategy to tackle counterfeits
Authors
Abstract
Steve Chaplin describes the MHRA's latest strategy to combat fake medicines through communication, collaboration and regulation. Copyright © 2008 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.288 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
